Edwards Lifesciences EW Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Edwards Lifesciences in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The official record: Edwards Lifesciences’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Edwards Lifesciences's operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Edwards Lifesciences's operating cash flow?
- Edwards Lifesciences (EW) reported operating cash flow of $43.8M in Q1 2026.
- How has Edwards Lifesciences's operating cash flow changed year-over-year?
- Edwards Lifesciences's operating cash flow decreased by 84.4% year-over-year, from $280.4M to $43.8M.
- What is the long-term trend for Edwards Lifesciences's operating cash flow?
- Over 3 years (2021 to 2025), Edwards Lifesciences's operating cash flow has grown at a -2.7% compound annual growth rate (CAGR), from $1.73B to $1.6B.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.